ProShares Ultra Nasdaq Biotechnology (BIB)
NASDAQ: BIB · Real-Time Price · USD
86.41
-0.97 (-1.11%)
At close: Feb 20, 2026, 4:00 PM EST
86.17
-0.24 (-0.28%)
After-hours: Feb 20, 2026, 4:29 PM EST
BIB Holdings Information
BIB is an equity ETF with a total of 270 individual holdings.
Total Holdings
270
Top 10 Percentage
153.47%
Asset Class
Equity
ETF Category
Trading--Leveraged Equity
Assets
91.38M
PE Ratio
n/a
Breakdown by Sector
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | n/a | NASDAQ BIO INDEX SWAP BNP PARIBAS | 41.39% |
| 2 | n/a | NASDAQ BIOTECHNOLOGY INDEX SWAP CITIBANK NA | 28.91% |
| 3 | n/a | NASDAQ BIOTECHNOLOGY INDEX SWAP BANK OF AMERICA NA | 22.66% |
| 4 | n/a | NASDAQ BIOTECHNOLOGY INDEX SWAP GOLDMAN SACHS INTERNATIONAL | 17.28% |
| 5 | n/a | NASDAQ BIOTECHNOLOGY INDEX SWAP SOCIETE GENERALE | 16.27% |
| 6 | GILD | Gilead Sciences, Inc. | 6.66% |
| 7 | AMGN | Amgen Inc. | 6.03% |
| 8 | VRTX | Vertex Pharmaceuticals Incorporated | 6.00% |
| 9 | n/a | NASDAQ BIOTECHNOLOGY INDEX SWAP UBS AG | 4.15% |
| 10 | REGN | Regeneron Pharmaceuticals, Inc. | 4.12% |
| 11 | ALNY | Alnylam Pharmaceuticals, Inc. | 2.29% |
| 12 | INSM | Insmed Incorporated | 1.75% |
| 13 | BIIB | Biogen Inc. | 1.44% |
| 14 | ARGX | argenx SE | 1.26% |
| 15 | UTHR | United Therapeutics Corporation | 1.06% |
| 16 | INCY | Incyte Corporation | 1.02% |
| 17 | RVMD | Revolution Medicines, Inc. | 1.01% |
| 18 | MRNA | Moderna, Inc. | 0.99% |
| 19 | RPRX | Royalty Pharma plc | 0.98% |
| 20 | ROIV | Roivant Sciences Ltd. | 0.98% |
| 21 | VTRS | Viatris Inc. | 0.94% |
| 22 | ILMN | Illumina, Inc. | 0.94% |
| 23 | ASND | Ascendis Pharma A/S | 0.72% |
| 24 | GH | Guardant Health, Inc. | 0.70% |
| 25 | BBIO | BridgeBio Pharma, Inc. | 0.70% |
As of Feb 19, 2026